Ohnari K, Yamano M, Uozumi T, Hashimoto T, Tsuji S, Nakagawa M
Dept. of Neurology, University of Occupational and Environmental Health, School of Medicine Yahatanishi-ku, Kitakyushu, 807-8555, Japan.
J Neurol. 2007 Oct;254(10):1390-4. doi: 10.1007/s00415-007-0557-0. Epub 2007 Oct 15.
Glial fibrillary acidic protein (GFAP) mutation has been reported in Alexander disease. We report a patient with the adult form of Alexander disease who shows a novel mutation in GFAP. This case presented with progressive dysarthria, dysphagia and spastic gait on the right side. Brain and spinal cord MRI showed marked atrophy of the medulla oblongata and spinal cord. Abnormal high signal intensities in the ventral medulla oblongata were detected bilaterally. There were no white matter lesions or contrast enhancing lesions. Recently, there have been reports of patients with a juvenile form of Alexander disease presenting with atrophy or signal abnormalities of the medulla or spinal cord. Atrophy of the medulla and spinal cord have specifically been described as suggestive of Alexander disease [1]. Sequence analysis of the GFAP gene of this patient showed a heterozygous c.221T>C mutation, predicting a p.M74T amino acid change. In all patients suspected of Alexander disease on the basis of MRI findings, GFAP analysis is necessary to confirm the diagnosis.
据报道,亚历山大病存在胶质纤维酸性蛋白(GFAP)突变。我们报告了一例成年型亚历山大病患者,其GFAP基因出现了一种新的突变。该病例表现为进行性构音障碍、吞咽困难和右侧痉挛性步态。脑和脊髓磁共振成像(MRI)显示延髓和脊髓明显萎缩。双侧延髓腹侧检测到异常高信号强度。未发现白质病变或强化病变。最近,有报道称青少年型亚历山大病患者出现延髓或脊髓萎缩或信号异常。延髓和脊髓萎缩被特别描述为提示亚历山大病[1]。对该患者的GFAP基因进行序列分析,显示存在杂合的c.221T>C突变,预测会发生p.M74T氨基酸变化。对于所有基于MRI结果怀疑患有亚历山大病的患者,进行GFAP分析对于确诊是必要的。